Frequency Therapeutics takes in $32 mln Series A

Woburn, Massachusetts-based Frequency Therapeutics, a developer of drugs that activate progenitor cells within the body, has secured $32 million in Series A financing. CoBro Ventures led the round with participation from other investors that included Morningside Ventures, Emigrant Capital Corp, Korean Investment Partnership and Alexandria Real Estate Equities.

Source: Press Release